{"id":"glucose-25-oral-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia (rebound high blood sugar)"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a simple carbohydrate replacement therapy that delivers glucose directly into the bloodstream via oral absorption. It is used to treat acute hypoglycemia (low blood sugar) by providing readily available glucose that can be quickly metabolized to restore normal blood glucose levels. The 25% concentration allows for rapid absorption and fast symptom relief in hypoglycemic episodes.","oneSentence":"Glucose 25% oral solution provides a concentrated source of glucose to rapidly raise blood sugar levels in hypoglycemic patients.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:36:47.497Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypoglycemia treatment"},{"name":"Symptomatic low blood sugar in pediatric and adult patients"}]},"trialDetails":[{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT07079930","phase":"PHASE1","title":"Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2025-12-11","conditions":"Healthy Volunteers","enrollment":10},{"nctId":"NCT07198100","phase":"NA","title":"tVNS, Motivation, and Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Bonn","startDate":"2025-10-10","conditions":"Major Depressive Disorder (MDD)","enrollment":120},{"nctId":"NCT07150819","phase":"NA","title":"A Multidisciplinary Perioperative Pain Management","status":"WITHDRAWN","sponsor":"China-Japan Friendship Hospital","startDate":"2022-07-01","conditions":"Anorectal Surgery, Pain Management","enrollment":""},{"nctId":"NCT06170905","phase":"NA","title":"Whey Protein Pre-load and Postprandial Glycemia in Pregnancy","status":"COMPLETED","sponsor":"University of Ulm","startDate":"2024-02-01","conditions":"Pregnancy, Postprandial Glycemia","enrollment":21},{"nctId":"NCT07237841","phase":"NA","title":"Preoperative Carbohydrate Loading in Diabetes Mellitus","status":"COMPLETED","sponsor":"Gia Dinh People Hospital","startDate":"2023-03-01","conditions":"Type2diabetes, Enhanced Recovery After Surgery (ERAS), Fasting","enrollment":76},{"nctId":"NCT07049172","phase":"NA","title":"Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome","status":"COMPLETED","sponsor":"Wuhan Children's Hospital","startDate":"2021-01-01","conditions":"Nephrotic Syndrome in Children","enrollment":91},{"nctId":"NCT05411991","phase":"PHASE4","title":"Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment","status":"COMPLETED","sponsor":"Vrije Universiteit Brussel","startDate":"2022-06-12","conditions":"Acute Heart Failure, Diuretics Drug Reactions","enrollment":107},{"nctId":"NCT06742398","phase":"NA","title":"Carbohydrates and Running Performance","status":"COMPLETED","sponsor":"University of Georgia","startDate":"2024-02-16","conditions":"Nutrition, Healthy","enrollment":36},{"nctId":"NCT06959290","phase":"NA","title":"Effect of Multiple Non-pharmacological Methods for Pain Management During Eye Examination for Retinopathy of Prematurity in Preterm Infants","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2025-05-01","conditions":"Premature Infant, Retinopaty of Prematurity, Pain Management","enrollment":24},{"nctId":"NCT03049189","phase":"PHASE3","title":"Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITM Solucin GmbH","startDate":"2017-02-02","conditions":"Neuroendocrine Tumors","enrollment":309},{"nctId":"NCT06358716","phase":"NA","title":"Glycaemic Index Determination in Oral Nutrition Supplements","status":"RECRUITING","sponsor":"Universitat de Lleida","startDate":"2024-04-15","conditions":"Glucose Metabolism Disorders","enrollment":15},{"nctId":"NCT05257031","phase":"PHASE3","title":"Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2022-02-12","conditions":"Nutrition Therapy, Critical Illness","enrollment":56},{"nctId":"NCT04946552","phase":"NA","title":"Sympathetic Activation in Obesity","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-11-23","conditions":"Obesity, Healthy","enrollment":5},{"nctId":"NCT05687409","phase":"PHASE4","title":"Synbiotics Interventions for Managing Cirrhosis and Its Complications","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2019-11-24","conditions":"Cirrhosis, Liver, Metagonimiasis","enrollment":120},{"nctId":"NCT02697253","phase":"PHASE2","title":"Mechanisms Underlying Predictors of Success From Obesity Surgery","status":"WITHDRAWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2016-01","conditions":"Obesity","enrollment":""},{"nctId":"NCT05179031","phase":"NA","title":"Assessment of the Glycemic Responses to Nutritional Products","status":"COMPLETED","sponsor":"Nutricia Research","startDate":"2022-01-04","conditions":"Glycemic Response","enrollment":13},{"nctId":"NCT05181514","phase":"NA","title":"Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity","status":"COMPLETED","sponsor":"Azienda Ospedaliero, Universitaria Pisana","startDate":"2019-04-30","conditions":"Hypertriglyceridemia, Glucose Intolerance","enrollment":12},{"nctId":"NCT02145247","phase":"NA","title":"Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-05","conditions":"Polycystic Ovary Syndrome","enrollment":39},{"nctId":"NCT02404025","phase":"PHASE2","title":"Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-05-12","conditions":"Aplastic Anemia","enrollment":10},{"nctId":"NCT03315338","phase":"PHASE1","title":"First-in-human Study in Healthy Subjects","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2017-09-15","conditions":"Healthy","enrollment":143},{"nctId":"NCT02511041","phase":"PHASE1","title":"Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-06-30","conditions":"PGM3","enrollment":2},{"nctId":"NCT01253889","phase":"PHASE4","title":"Sweetheart Study: Oral Glucose for Reducing Stress During Echocardiographic Assessment in Infants in the NICU","status":"COMPLETED","sponsor":"Children's & Women's Health Centre of British Columbia","startDate":"2010-12","conditions":"Cardiac Echocardiography Assessment","enrollment":104},{"nctId":"NCT01664624","phase":"PHASE1","title":"Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-07","conditions":"Type 2 Diabetes","enrollment":40},{"nctId":"NCT01965873","phase":"PHASE4","title":"Enteral Nutrition in Acute Pancreatitis","status":"COMPLETED","sponsor":"University Hospital Rijeka","startDate":"2007-05","conditions":"Acute Pancreatitis","enrollment":214},{"nctId":"NCT01596062","phase":"PHASE2","title":"Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-03","conditions":"Renal Transplantation","enrollment":16},{"nctId":"NCT00808054","phase":"PHASE4","title":"Evaluation of Analgesia With EMLA and Glucose Oral Solution","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2008-11","conditions":"Pain","enrollment":60},{"nctId":"NCT01828671","phase":"NA","title":"A Study to Examine the Glycemic Response of Corn and Soy Tortillas in Healthy Individuals","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2013-12","conditions":"Healthy","enrollment":10},{"nctId":"NCT01121835","phase":"PHASE4","title":"Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-02","conditions":"Diabetes Mellitus, Type 2","enrollment":934},{"nctId":"NCT00787761","phase":"PHASE2","title":"Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer","status":"COMPLETED","sponsor":"Northside Hospital, Inc.","startDate":"2007-04","conditions":"Myeloproliferative Disorders, Kidney Cancer, Leukemia","enrollment":24},{"nctId":"NCT01199900","phase":"PHASE1","title":"Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-08","conditions":"Healthy","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["glucose","Water for injection","water for injection once per os"],"phase":"marketed","status":"active","brandName":"Glucose 25% oral solution","genericName":"Glucose 25% oral solution","companyName":"Children's & Women's Health Centre of British Columbia","companyId":"children-s-women-s-health-centre-of-british-columbia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucose 25% oral solution provides a concentrated source of glucose to rapidly raise blood sugar levels in hypoglycemic patients. Used for Acute hypoglycemia treatment, Symptomatic low blood sugar in pediatric and adult patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}